Selection and Recombinant Phenotyping of a Novel CMX001 and Cidofovir Resistance Mutation in Human Cytomegalovirus

First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses

(2012) Wendy Painter et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Progress in the development of new therapies for herpesvirus infections

(2011) Nathan B Price et al.   Current Opinion in Virology

Antiviral Drug Resistance of Human Cytomegalovirus

(2010) N. S. Lurain et al.   CLINICAL MICROBIOLOGY REVIEWS

The search for new therapies for human cytomegalovirus infections

(2010) Mark N. Prichard et al.   VIRUS RESEARCH

Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art

(2009) Karl Y. Hostetler   ANTIVIRAL RESEARCH

The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation

(2009) Mark Tuthill et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunocompromised Hosts: Perspectives in the Treatment and Prophylaxis of Cytomegalovirus Disease in Solid‐Organ Transplant Recipients

(2008) Gilberto Torres‐Madriz et al.   CLINICAL INFECTIOUS DISEASES

Human Cytomegalovirus UL97 Kinase Activity Is Required for the Hyperphosphorylation of Retinoblastoma Protein and Inhibits the Formation of Nuclear Aggresomes

(2008) M. N. Prichard et al.   JOURNAL OF VIROLOGY